Topics - Drug Development
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
Published April 29, 2013
Will combine SGLT2 inhibitor with Januvia Read More »
Published April 26, 2013
Separates late-stage partnered assets from biopharma operations Read More »
Published April 23, 2013
Manufactures cancer treatment materials at Slough Read More »
Published April 23, 2013
Will provide development activities for monoclonal antibody program Read More »
Published April 18, 2013
Will increase staff at Billerica site by 20% Read More »
Published April 17, 2013
Will focus on respiratory disease Read More »
Published April 16, 2013
Xencor to receive upfront payment, eligible for milestones and royalties Read More »
Published April 16, 2013
Will initially develop and commercialize six products Read More »
Published April 15, 2013
Aims to identify novel small molecule and antibody targets Read More »
Published April 12, 2013
Boehringer provides funding through Phase IIa for ophthalmics Read More »
Published April 11, 2013
Dalton to synthesize and manufacture selected drug candidates Read More »
By Gil Roth
Published April 11, 2013
Five-year pact covers central lab work, biomarker testing and assay development Read More »
Published April 10, 2013
Takes minority equity stake in Redwood Bioscience Read More »
Published April 5, 2013
Will evaluate VX-135 and daclatasvir in hepatitis C Read More »
